Managing Your Digical Ulcer PDF Print E-mail
Thursday, 19 August 2010 12:49
Around 40% of patients with Scleroderma develop open sores on their fingertips called digital ulcers. In some patients, this is the major ongoing difficulty whereas in others, digital ulcers are an uncommon and short term complication.

Digital ulcers occur because of poor blood flow to the fingertips which is in turn related to the narrowing of blood vessels that is the hallmark of all forms of Systemic Scleroderma.

Digital ulcers are tightly linked with Raynaud's phenomenon. They both occur in Scleroderma because of narrowed blood vessels. Raynaud attacks occur daily and are clearly worsened by cold weather. Digital ulcers can occur at anytime of the year and in any weather.

The fingertips in Scleroderma should be cared for in much the way a patient with diabetes might care for their feet.
  • Keep the skin moist and supple. Hand creams rich in lanolin can help.
  • Protect the fingertips. Avoid tasks that risk fingertip trauma.
  • Treat cuts promptly and thoroughly. Don’t let infection get established.
  • Control your Raynaud’s phenomenon more effectively. This requires working closely with your physician to choose the best program of medication.
  • Keep your physician involved. Let him or her know when an ulcer has started. The earlier it is treated, the better the outcome.

The Scleroderma research community is actively investigating treatments for digital ulcers. In Europe, intravenous iloprost (Ilomedin®) is approved and widely used, although this therapy is not available in the U.S. Recent studies with bosentan (Tracleer®), an agent approved by the FDA for pulmonary hypertension, have suggested an effect in preventing digital ulcers. Other research projects are in early stages of planning.

Source: University of Michigan Health System
 
More articles :

» Adult Stem Cells Are Helping Scleroderma Patients

Dr. Richard Burt and colleagues at Northwestern University have just published a new study in that provides more evidence for the success of adult stem cell transplant in treating System Sclerosis ().Ten patients were treated with their own adult...

» Juvenile Localized Scleroderma: Fewer Flares With Methotrexate

was an effective and well-tolerated treatment for in a randomized, double-blind, placebo-controlled trial involving 70 patients with active disease. At the end of the 12-month study, 31 of 46 patients randomized to receive methotrexate had...

» Rituximab Shows Promise in Scleroderma

Rituximab (Rituxan) improved lung function in patients with , a small proof-of-principle study found.At one year, patients randomized to receive rituximab had a median 10.25% increase in forced vital capacity (FVC) compared with baseline, while...

» Important Information About Autoimmune Diseases

There are more than 100 known autoimmune disorders, including rheumatoid arthritis, type 1 diabetes, scleroderma, and lupus. Normally, your immune system is designed to protect your health. But in some people, the immune system creates...

» A System Out of Breath: How Hypoxia Possibly Contributes to the Pathogenesis of Systemic Sclerosis

T. W. van Hal, L. van Bon, and T. R. D. J. RadstakeReceived 20 May 2011; Revised 18 August 2011; Accepted 7 September 2011Systemic sclerosis (SSc) is typified by vascular alterations and immunological disturbances and fibrosis of the skin and...

» Unite Against Scleroderma 2014

For the fourth year running, we will be hosting our annual “Unite Against Scleroderma” Awareness Walk. Scheduled to start from 2:30pm, the Walk would be held on Saturday 3rd May, 2014 and cover one full lap around the Queen’s Park Savannah,...